MedTrace Logo

Distal Versus Proximal Protection on Cerebral Microembolization During High-risk Carotid Artery Stenting

NCT04872127 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-10-12

No results posted yet for this study

Summary

A multicenter, prospective, outcome-assessor-blinded, randomized controlled trial study (MOSCASH) is designed to compare the efficiency of distal and proximal embolism protection devices during carotid angioplasty and stenting (CAS) procedure of patients with high-intensity signal in the plaque on the time-of-flight magnetic resonance angiography(TOF-MRA) .

Conditions

Interventions

DEVICE

proximal embolism protection device

a proximal occlusion Mo.Ma will be used as the embolism protection device during CAS

DEVICE

distal embolism protection device

a distal SpiderFX will be used as the embolism protection device during CAS

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Liqun Jiao, MD, PhD · Department of Neurosurgery & Interventional Neuroradiology Xuanwu Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2023-05-01
Completion
2024-02-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04872127 on ClinicalTrials.gov